{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:07:06Z","timestamp":1789495626835,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20760"],"award-info":[{"award-number":["U24A20760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jvir.2026.107994","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:58:23Z","timestamp":1768291103000},"page":"107994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Transarterial Embolization Combined with Chemotherapy on Regulatory T Cells and Vascular Endothelial Growth Factor in the Tumor Immune Microenvironment of Intrahepatic Cholangiocarcinoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Jingxi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-590X","authenticated-orcid":false,"given":"Feng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2026.107994_bib1","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2026.107994_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/cncr.34541","article-title":"The multidisciplinary management of cholangiocarcinoma","volume":"129","author":"Ohaegbulam","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2026.107994_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jvir.2026.107994_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jvir.2026.107994_bib5","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.3390\/cancers16203542","article-title":"Tumor immune microenvironment in intrahepatic cholangiocarcinoma: regulatory mechanisms, functions, and therapeutic implications","volume":"16","author":"Ricci","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2026.107994_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","article-title":"Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"127","author":"Konishi","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2026.107994_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13046-022-02340-2","article-title":"The role of tumor-infiltrating lymphocytes in cholangiocarcinoma","volume":"41","author":"Liu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jvir.2026.107994_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jvir.2026.107994_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189079","article-title":"VEGF signaling: role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jvir.2026.107994_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/JLB.5RU0222-082R","article-title":"Direct and indirect regulation of the tumor immune microenvironment by VEGF","volume":"111","author":"Zhang","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jvir.2026.107994_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616837","article-title":"Direct and indirect modulation of T cells by VEGF-A counteracted by anti-angiogenic treatment","volume":"12","author":"Bourhis","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvir.2026.107994_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jvir.2026.107994_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117080","article-title":"Tumor-infiltrating T lymphocytes: a promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma","volume":"177","author":"Hua","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jvir.2026.107994_bib14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00535-023-02012-8","article-title":"Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma","volume":"58","author":"Peng","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jvir.2026.107994_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2026.107994_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/bgh037","article-title":"Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma","volume":"25","author":"Yeh","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jvir.2026.107994_bib17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2026.107994_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1258\/0023677054307051","article-title":"Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat","volume":"39","author":"Garin","year":"2005","journal-title":"Lab Anim"},{"key":"10.1016\/j.jvir.2026.107994_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1148\/radiol.211028","article-title":"Transarterial embolization modulates the immune response within target and nontarget hepatocellular carcinomas in a rat model","volume":"303","author":"Tischfield","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2026.107994_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.25756","article-title":"Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells","volume":"129","author":"Rettig","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jvir.2026.107994_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.27990","article-title":"Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer","volume":"133","author":"Shevchenko","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jvir.2026.107994_bib22","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2147\/OTT.S69830","article-title":"Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model","volume":"7","author":"Zhou","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jvir.2026.107994_bib23","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jvir.2018.07.005","article-title":"Modified rat hepatocellular carcinoma models overexpressing vascular endothelial growth factor","volume":"29","author":"Choi","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.107994_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5604\/01.3001.0012.0948","article-title":"Rapamycin combi with TAE on the growth, metastasis, and prognosis of hepatocellular carcinoma in rat models","volume":"17","author":"Lei","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jvir.2026.107994_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00270-019-02343-1","article-title":"Hepatic arterial bland embolization increases Th17 cell infiltration in a syngeneic rat model of hepatocellular carcinoma","volume":"43","author":"Avritscher","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.107994_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cas.16013","article-title":"T-cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood","volume":"115","author":"Li","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jvir.2026.107994_bib27","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/hepr.14188","article-title":"Peripheral blood CD4+\/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: preliminary report","volume":"55","author":"Kawamura","year":"2025","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jvir.2026.107994_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216709","article-title":"S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE\/NF-kB\/VEGF-D pathway","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jvir.2026.107994_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jvir.2026.107994_bib30","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3390\/cancers15102738","article-title":"Targeting hypoxia-inducible factor-1\u03b1 for the management of hepatocellular carcinoma","volume":"15","author":"Huynh","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2026.107994_bib31","doi-asserted-by":"crossref","first-page":"W11","DOI":"10.2214\/AJR.13.12412","article-title":"CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression","volume":"204","author":"Kambadakone","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2026.107994_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/diagnostics13030521","article-title":"Dynamic contrast-enhanced magnetic resonance imaging for measuring perfusion in pancreatic ductal adenocarcinoma and different tumor grade: a preliminary single center study","volume":"13","author":"Zaborien\u0117","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jvir.2026.107994_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:25:16Z","timestamp":1774254316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044326000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1051044326000059"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2026.107994","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Transarterial Embolization Combined with Chemotherapy on Regulatory T Cells and Vascular Endothelial Growth Factor in the Tumor Immune Microenvironment of Intrahepatic Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2026.107994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier, Inc., on behalf of SIR.","name":"copyright","label":"Copyright"}],"article-number":"107994"}}